Myocardial Perfusion Assessment With Multidetector Computed Tomography
NCT00846079
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Regadenoson (Lexiscan) [muti-detector computed tomography]
Sponsor
Tennessee Heart and Vascular Institute, P.C.
Collaborators
[object Object]